secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2025-04-08T23:59:59+00:00
Accession:  0001628280-25-017006
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE Health reports preliminary Q1 2025 revenue of $9.1M-$9.3M, up 57-61% YoY
--------------------------------------------------------------------------------

- Preliminary Q1 2025 revenue $9.1M-$9.3M, highest Q1 in company history; +57-61% vs Q1 2024.
- UltraMIST revenue up >65% YoY, constitutes ~99% of total revenues.
- Results slightly above upper end of guidance given in Q4 2024 earnings release (March 21, 2025).
- CEO Morgan Frank notes sales force restructuring complete; all manufacturing domestic, no significant tariff impact.
- Full Q1 2025 results expected around May 9, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/0001628280-25-017006-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000162828025017006/snwv-20250408.htm
  HTML page:      https://secwatch.observer/filing/0001628280-25-017006

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer